These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
306 related items for PubMed ID: 10369628
21. Ziprasidone- and lithium-induced neuroleptic malignant syndrome. Borovicka MC, Bond LC, Gaughan KM. Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776 [Abstract] [Full Text] [Related]
22. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome. Musselman ME, Browning LA, Parker D, Saely S. Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252 [Abstract] [Full Text] [Related]
23. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management. Perry PJ, Wilborn CA. Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571 [Abstract] [Full Text] [Related]
24. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units]. Franzen D, Burkhard J, Corti N, Schüpbach D, Fontanel D, Stäubli M. Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563 [Abstract] [Full Text] [Related]
25. Rechallenging clozapine after neuroleptic malignant syndrome. Anbalagan E, Ithman M, Lauriello J. Psychiatr Q; 2014 Sep; 85(3):345-8. PubMed ID: 24633526 [Abstract] [Full Text] [Related]
26. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. Sokoro AA, Zivot J, Ariano RE. Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660 [Abstract] [Full Text] [Related]
27. NMS after clozapine initiation. Skarpathiotakis M, Westreich N. J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854 [No Abstract] [Full Text] [Related]
28. Clozapine-induced neuroleptic malignant syndrome: clozapine monotherapy rechallenge in a case of previous NMS. Illing M, Ancill R. Can J Psychiatry; 1996 May; 41(4):258. PubMed ID: 8726793 [No Abstract] [Full Text] [Related]
35. [Clozapine: a neuroleptic at risk of provoking neuroleptic malignant syndrome (NMS) or an alternative neuroleptic with positive NMS case histories?]. Weller M, Kornhuber J. Fortschr Neurol Psychiatr; 1993 Jun 08; 61(6):217-22. PubMed ID: 8330832 [Abstract] [Full Text] [Related]
37. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, Innamorati M, Pompili M, Amore M. Drugs R D; 2015 Mar 08; 15(1):45-62. PubMed ID: 25578944 [Abstract] [Full Text] [Related]
38. Atypical neuroleptic malignant syndrome associated with clozapine treatment. Amore M, Zazzeri N, Berardi D. Neuropsychobiology; 1997 Mar 08; 35(4):197-9. PubMed ID: 9246221 [Abstract] [Full Text] [Related]